Regulatory Process Overview – BASIC INFORMATION
Population Distribution in Japan (2023)
Source：https://www.populationpyramid.net/
Cancer incidence in Japan（2017-2020）
| 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|
| All sites (including carcinoma in situ) | 1,093,280 | 1,099,164 | 1,123,038 | 1,055,728 |
| Large intestine (including carcinoma in situ) | 195,188 | 193,900 | 199,099 | 186,298 |
| Colon (including carcinoma in situ) | 132,303 | 131,487 | 134,735 | 126,202 |
| Lung (including carcinoma in situ) | 124,758 | 125,636 | 129,562 | 123,418 |
| Stomach | 129,476 | 126,009 | 124,319 | 109,679 |
| Breast (including carcinoma in situ) | 104,379 | 106,583 | 110,728 | 103,744 |
| Prostate | 91,215 | 92,021 | 94,749 | 87,756 |
| Rectum (including carcinoma in situ) | 62,885 | 62,413 | 64,364 | 60,096 |
| Uterus (including carcinoma in situ) | 51,291 | 52,346 | 53,247 | 50,873 |
| Bladder (including carcinoma in situ) | 42,627 | 43,242 | 44,096 | 43,270 |
| Pancreas | 40,981 | 42,361 | 43,865 | 44,448 |
Source: Cancer Statistics. Cancer Information Service, National Cancer Center, Japan (National Cancer Registry, Ministry of Health, Labour and Welfare)
Intractable diseases data (2022)
| Number of patients |
*Patient associations, etc. |
|
|---|---|---|
| Parkinson’s disease | 143,267 | X |
| Colitis ulcerative | 141,387 | X |
| Systemic lupus erythematosus | 65,145 | X |
| Crohn’s disease | 50,184 | X |
| Ossification of the posterior longitudinal ligament | 31,571 | X |
| Systemic Scleroderma | 27,013 | X |
| Spinocerebellar Degeneration (Excluding multiple system atrophy.) | 26,476 | X |
| Myasthenia Gravis | 26,387 | X |
| Dermatomyositis/Polymyositis | 26,046 | |
| Multiple sclerosis/Neuromyelitis optica | 23,105 | X |
| Eosinophilic sinusitis | 22,340 | |
| Retinitis pigmentosa | 21,263 | X |
- Numbers of designated intractable diseases: 341 (as of 1st April 2024)
- Ask CRO in Japan when you need detail information of Patient Associations
- Listed more than 20,000 patients designated intractable diseases. Other intractable diseases are also designated by Japan government, ask CRO in Japan when you need information of other designated intractable diseases.
*According to Japan CRO association’s research